The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-xL proteins
Abstract
Elevation of serum interleukin-6 (IL-6) levels is always associated with alcoholic liver disease (ALD), but the significance of such elevation is not clear. Here we show that chronic ethanol consumption induces significant apoptosis in the liver of IL-6 (-/-) mice but not IL-6 (+/+) mice. IL-6 (-/-) hepatocytes are more susceptible to ethanol- and tumor necrosis factor alpha- (TNFalpha-) induced apoptotic killing, which can be corrected by IL-6. Expression of both anti-apoptotic (such as Bcl-2 and Bcl-x(L)) and proapoptotic (such as Bax) proteins is markedly elevated in the liver of human ALD and chronically ethanol-fed IL-6 (+/+) mice. On the contrary, induction of Bcl-2 and Bcl-x(L) is not observed in the liver of chronically ethanol-fed IL-6 (-/-) mice, whereas expression of Bax protein remains elevated. Injection of IL-6 markedly induces expression of Bcl-2 and Bcl-x(L) but not Bax in the liver. Finally, high concentrations of ethanol inhibit IL-6-activated anti-apoptotic signal, but increasing the concentrations of IL-6 is able to overcome such inhibitory effect. These findings suggest that elevated serum IL-6 levels in ALD may overcome the inhibitory effect of ethanol on IL-6-mediated anti-apoptotic signals and prevent alcohol-induced hepatic apoptosis by induction of Bcl-2 and Bcl-x(L).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increasing evidence demonstrates that IL-6 has a protective role during liver injury.”
From The IL-6–gp130–STAT3 pathway in hepatocytes triggers liver protection in T cell–mediated liver injury (2005) · cites this paper as [4]
Citations
Cites
Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,538
Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice
Kovalovich, K., DeAngelis, R. A., Li, W., Furth, E. E., Ciliberto, G., & Taub, R. (2000) · Hepatology · doi:10.1002/hep.510310123 · Cited by 298
Galun, E., Zeira, E., Pappo, O., Peters, M., & Rose-John, S. (2000) · The FASEB Journal · doi:10.1096/fj.99-0913com · Cited by 124
Research works printed but not linked: 49
- Abittan CS, Lieber CS . 1999 Curr. Treat Options Gastroenterol. 2: 72–80 · DOI
- Adams JM, Cory S . 2001 Trends Biochem. Sci. 26: 61–66 · DOI
- Benedetti A, Brunelli E, Risicato R, Cilluffo T, Jezequel AM, Orlandi F . 1988 J. Hepatol. 6: 137–143 · DOI
- Chang YC, Xu YH . 2000 Cell Res. 10: 233–242 · DOI
- Chen J, Bao H, Sawyer S, Kunos G, Gao B . 1997 Biochem. Biophys. Res. Commun. 239: 666–669 · DOI
- Chen J, Ishac EJ, Dent P, Kunos G, Gao B . 1998 Biochem. J. 334: 669–676 · DOI
- Chen J, Kunos G, Gao B . 1999a FEBS Lett. 457: 162–168 · DOI
- Chen MC, Hsu TL, Luh TY, Hsieh SL . 2000 J. Biol. Chem. 275: 38794–38801 · DOI
- Chen RH, Chang MC, Su YH, Tsai YT, Kuo ML . 1999b J. Biol. Chem. 274: 23013–23019 · DOI
- Deaciuc IV, Alappat JM, McDonough KH, D'Souza NB . 1996 Alcohol. Clin. Exp. Res. 20: 293–301 · DOI
- Deaciuc IV, Fortunato F, D'Souza N, Hill D, McClain C . 2001 Hepatol. Res. 19: 306–324 · DOI
- Diehl AM . 1989 Med. Clin. North Am. 73: 815–830 · DOI
- Diehl AM . 1999a Alcohol. Clin. Exp. Res. 23: 1419–1424 · DOI
- Diehl AM . 1999b Clin. Biochem. 32: 571–578 · DOI
- Ezure T, Sakamoto T, Tsuji H, Lunz III JG, Murase N, Fung JJ, Demetris AJ . 2000 Am. J. Pathol. 156: 1627–1639 · DOI
- Fontanilla CV, Faunce DE, Gregory MS, Messingham KA, Durbin EA, Duffner LA, Kovacs EJ . 2000 Alcohol. Clin. Exp. Res. 24: 1392–1399 · DOI
- Fuchs D, Gruber A, Uberall F, Wachter H . 1994 Immunol. Today 15: 496 · DOI
- Goldin RD, Hunt NC, Clark J, Wickramasinghe SN . 1993 J. Pathol. 171: 73–76 · DOI
- Gonzalez-Quintela A, Dominguez-Santalla MJ, Perez LF, Vidal C, Lojo S, Barrio E . 2000 Cytokine 12: 1437–1440 · DOI
- Grad J, Zeng X, Boise L . 2000 Curr. Opin. Oncol. 12: 543–549 · DOI
- Hall PD . 1994 Alcohol. Suppl. 2: 303–313 · DOI
- Halsted CH, Villanueva J, Chandler CJ, Stabler SP, Allen RH, Muskhelishvili L, James SJ, Poirier L . 1996 Hepatology 23: 497–505 · DOI
- Hecht N, Pappo O, Shouval D, Rose-John S, Galun E, Axelrod JH . 2001 Mol. Ther. 3: 683–687 · DOI
- Hong F, Nguyrn VA, Gao B . 2001 FASEB J. 15: 1595–1597 · DOI
- Hong F, Nguyen VA, Shen X, Kunos G, Gao B . 2000 Biochem. Biophys. Res. Commun. 279: 974–979 · DOI
- Kamimura S, Tsukamoto H . 1995 Hepatology 22: 1304–1309 · DOI
- Kim W, Hong F, Jaruga B, Hu Z, Fan S, Liang J, Gao B . 2001 FASEB J. 15: in press · DOI
- Kovalovich K, Li W, DeAngelis R, Greenbaum LE, Ciliberto G, Taub R . 2001 J. Biol. Chem. 276: 26605–26613 · DOI
- Kuo ML, Chuang SE, Lin MT, Yang SY . 2001 Oncogene 20: 677–685 · DOI
- Kurose I, Higuchi H, Miura S, Saito H, Watanabe N, Hokari R, Hirokawa M, Takaishi M, Zeki S, Nakamura T, Ebinuma H, Kato S, Ishii H . 1997 Hepatology 25: 368–378 · DOI
- Lacronique V, Mignon A, Fabre M, Viollet B, Rouquet N, Molina T, Porteu A, Henrion A, Bouscary D, Varlet P, Joulin V, Kahn A . 1996 Nat. Med. 2: 80–86 · DOI
- Laso FJ, Iglesias-Osma C, Ciudad J, Lopez A, Pastor I, Orfao A . 1999 Alcohol. Clin. Exp. Res. 23: 1306–1311 · DOI
- Maddrey WC . 2000 Clin. Liver Dis. 4: 115–131 vii · DOI
- Martinez F, Abril ER, Earnest DL, Watson RR . 1992 Alcohol 9: 455–458 · DOI
- McClain CJ, Barve S, Deaciuc I, Kugelmas M, Hill D . 1999 Semin. Liver Dis. 19: 205–219 · DOI
- Mi LJ, Mak KM, Lieber CS . 2000 Alcohol. Clin. Exp. Res. 24: 207–212 · DOI
- Panesar N, Tolman K, Mazuski JE . 1999 J. Surg. Res. 85: 251–258 · DOI · Paper page
- Pastorino JG, Hoek JB . 2000 Hepatology 31: 1141–1152 · DOI
- Pennington HL, Hall PM, Wilce PA, Worrall S . 1997 J. Gastroenterol. Hepatol. 12: 305–313 · DOI
- Rashid A, Wu TC, Huang CC, Chen CH, Lin HZ, Yang SQ, Lee FY, Diehl AM . 1999 Hepatology 29: 1131–1138 · DOI
- Rollwagen FM, Yu ZY, Li YY, Pacheco ND . 1998 Clin. Immunol. Immunopathol 89: 205–213 · DOI
- Sasaki Y, Wands JR . 1994 Biochem. Biophys. Res. Commun. 199: 403–409 · DOI
- Slomiany A, Piotrowski E, Grabska M, Piotrowski J, Slomiany BL . 1999 Alcohol. Clin. Exp. Res. 23: 334–343 · DOI
- Tuma DJ, Todero SL, Barak-Bernhagen M, Sorrell MF . 1996 Alcohol. Clin. Exp. Res. 20: 579–583 · DOI
- Walsh K, Alexander G . 2000 Postgrad. Med. J. 76: 280–286 · DOI
- Ward NS, Waxman AB, Homer RJ, Mantell LL, Einarsson O, Du Y, Elias JA . 2000 Am. J. Respir. Cell. Mol. Biol. 22: 535–542 · DOI
- Yacoub LK, Fogt F, Griniuviene B, Nanji AA . 1995 Alcohol. Clin. Exp. Res. 19: 854–859 · DOI
- Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, Luster MI, Thurman RG . 1999 Gastroenterology 117: 942–952 · DOI
- Zhao M, Laissue JA, Zimmermann A . 1997 Virchows Arch 431: 337–344 · DOI
Cited by
Sorted by citations
Radaeva, S., Sun, R., Pan, H., Hong, F., & Gao, B. (2004) · Hepatology · doi:10.1002/hep.20184 · Cited by 638
Self-citationOpposing roles of STAT1 and STAT3 in T cell–mediated hepatitis: regulation by SOCS
Hong, F., Jaruga, B., Kim, W. H., Radaeva, S., El-Assal, O. N., Tian, Z., Nguyen, V.-A., & Gao, B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15841 · Cited by 294
“Additionally, induction of the antiapoptotic Bcl-XL protein expression in hepatocytes may be another mechanism contributing to IL-6/STAT3-mediated protection against Con A– induced liver injury because Bcl-XL, which is elevated and positively regulated by IL-6/STAT3 in Con A– induced hepatitis (Figure 2d and Figure 5a…”
Self-citationAdvanced body composition assessment: from body mass index to body composition profiling
Irace, C., de Rosa, S., Tripolino, C., Ambrosio, G., Covello, C., Abramo, E., Carallo, C., Mongiardo, A., Spaccarotella, C., Torella, D., et al. (2018) · Journal of Investigative Medicine · doi:10.1136/jim-2017-000618 · Cited by 313
Molecular Mechanisms of Alcoholic Fatty Liver
Purohit, V., Gao, B., & Song, B. (2009) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00827.x · Cited by 312
“…IL-6-deficient mice are more susceptible to alcohol-induced steatosis and liver injury, while treatment with IL-6 ameliorates alcohol-induced fatty liver and prevents mortality associated with alcoholic fatty liver transplants (El-Assal et al., 2004; Hong et al., 2002, 2004; Sun et al., 2003).”
Self-citationCellular and Mitochondrial Effects of Alcohol Consumption
Manzo‐Ávalos, S., & Saavedra‐Molina, A. (2010) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph7124281 · Cited by 303
“Treatment of steatosis with IL-6 induces expression of anti-apoptotic Bcl-xL protein in primary mouse hepatocytes [161],”
Background
Metadata
- Authors
- Hong, F., Kim, W.-H., Tian, Z., Jaruga, B., Ishac, E., Shen, X., & Gao, B.
- Affiliations
- National Institutes of Health (US)
- University of Science and Technology of China (CN)
- Virginia Commonwealth University (US)
- Corresponding author
- Gao, Bin
- Venue
- Oncogene
- Published
- 2002-01-03
- Volume
- 21
- Issue
- 1
- Pages
- 32-43
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2057210516
- Cited by
- 179
- References
- 0
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 5 · 2023: 4 · 2022: 4 · 2021: 8 · 2020: 10 · 2019: 7 · 2018: 7 · 2017: 10 · 2016: 8 · 2015: 6 · 2014: 6 · 2013: 7 · 2012: 11
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01aa012637-03)
- National Institute on Alcohol Abuse and Alcoholism (R01 AA 12637)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- interleukin-6, ethanol consumption, alcoholic liver disease, hepatocyte apoptosis, Bcl-2, Bcl-xL, Bax, TNF-α, anti-apoptotic signaling, IL-6 knockout mice
- MeSH terms
- Ethanol, Alcoholism, Animals, Body Weight, Cells, Cultured, Gene Expression Regulation, Genotype, Humans, Liver, Liver Diseases, Alcoholic, Male, Organ Size, Tumor Necrosis Factor-alpha, Interleukin-6, Apoptosis, Mice, Knockout, Proto-Oncogene Proteins c-bcl-2, Genes, bcl-2, Genetic Predisposition to Disease, Hepatocytes, bcl-X Protein, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review